BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12971334)

  • 1. FDA approves Gleevec for pediatric leukemia.
    FDA Consum; 2003; 37(4):6. PubMed ID: 12971334
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA approves Novartis' Gleevec.
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):3. PubMed ID: 12113126
    [No Abstract]   [Full Text] [Related]  

  • 3. STI-571 (Gleevec) in the treatment of chronic myeloid leukaemia.
    Kumar L; Kumari M; Menon H
    Natl Med J India; 2002; 15(5):298. PubMed ID: 12502149
    [No Abstract]   [Full Text] [Related]  

  • 4. Gleevec (STI-571) for chronic myeloid leukemia.
    Med Lett Drugs Ther; 2001 Jun; 43(1106):49-50. PubMed ID: 11402258
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).
    Hochhaus A
    Ann Hematol; 2004; 83 Suppl 1():S65-6. PubMed ID: 15124676
    [No Abstract]   [Full Text] [Related]  

  • 6. New leukemia drug receives FDA approval.
    Mayo Clin Health Lett; 2001 Jul; 19(7):4. PubMed ID: 11433951
    [No Abstract]   [Full Text] [Related]  

  • 7. Gleevec approved for first-line treatment of CML.
    FDA Consum; 2003; 37(2):5. PubMed ID: 12715753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of chronic myeloid leukemia by imatinib].
    Kizaki M
    Rinsho Ketsueki; 2010 Oct; 51(10):1377-85. PubMed ID: 20962470
    [No Abstract]   [Full Text] [Related]  

  • 9. A cancer 'smart bomb'. A new drug shows hope of conquering a form of leukemia by targeting the misbehaving cells.
    Kalb C
    Newsweek; 2000 Dec; 136(25):68. PubMed ID: 11126146
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiotoxicity of imatinib: At the heart of the problem.
    Tiribelli M; Medeot M
    Leuk Res; 2011 Jan; 35(1):36-7. PubMed ID: 20970188
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib-associated hyperpigmentation, a side effect that should be recognized.
    Mcpherson T; Sherman V; Turner R
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):82-3. PubMed ID: 18384557
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.
    Garipidou V; Vakalopoulou S; Tziomalos K
    Oncologist; 2005; 10(6):457-8. PubMed ID: 15967839
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure red cell aplasia in a patient of chronic granulocyte leukemia associated with imatinib.
    Meng HT; Li Y; Jin J; Qian WB; Yang CM
    Ann Hematol; 2007 Mar; 86(3):231-2. PubMed ID: 17123082
    [No Abstract]   [Full Text] [Related]  

  • 14. New leukemia drug shows promise against Gleevec resistance.
    Ashraf H
    Drug Discov Today; 2005 Apr; 10(7):453-4. PubMed ID: 15809187
    [No Abstract]   [Full Text] [Related]  

  • 15. Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
    Cashen A; DiPersio JF; Khoury H
    J Clin Oncol; 2003 Nov; 21(22):4255-6. PubMed ID: 14615462
    [No Abstract]   [Full Text] [Related]  

  • 16. In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
    Rosti G; Martinelli G; Baccarani M
    Nat Med; 2007 Jan; 13(1):15; author reply 15-6. PubMed ID: 17206121
    [No Abstract]   [Full Text] [Related]  

  • 17. In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
    Atallah E; Kantarjian H; Cortes J
    Nat Med; 2007 Jan; 13(1):14; author reply 15-6. PubMed ID: 17206119
    [No Abstract]   [Full Text] [Related]  

  • 18. In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
    Hatfield A; Owen S; Pilot PR
    Nat Med; 2007 Jan; 13(1):13; author reply 15-6. PubMed ID: 17206118
    [No Abstract]   [Full Text] [Related]  

  • 19. In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
    Gambacorti-Passerini C; Tornaghi L; Franceschino A; Piazza R; Corneo G; Pogliani E
    Nat Med; 2007 Jan; 13(1):13-4; author reply 15-6. PubMed ID: 17206117
    [No Abstract]   [Full Text] [Related]  

  • 20. Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: report of five cases.
    Breccia M; Cannella L; Montefusco E; Frustaci A; Pacilli M; Alimena G
    Leuk Res; 2008 Mar; 32(3):519-20. PubMed ID: 17804066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.